Found charges $129–$199/month for compounded semaglutide bundled with behavioral health coaching. For patients who won't consistently engage with the coaching, Luma Health at $197/month flat delivers the same active ingredient with named pharmacy transparency and no commitment — at comparable or lower pricing at maintenance doses. For patients who value Found's coaching and will use it, the bundle may be worth the premium.
The core question isn't whether Found or Luma Health is "better" — it's whether Found's coaching premium is worth it for your specific situation.
What Found Costs Without Insurance in 2026
Found Health operates on a cash-pay model — no insurance is required or accepted for their compounded GLP-1 program. Their pricing for compounded semaglutide uses dose-tier pricing that increases as you escalate from starting to maintenance doses, and the total includes a behavioral coaching bundle that cannot be removed from the subscription.
Found Cash-Pay Pricing — Semaglutide 2026
The key insight for cash-pay patients evaluating Found: the behavioral coaching bundle is a meaningful part of Found's monthly charge that applies regardless of whether you engage with it. If you enroll primarily for GLP-1 access and don't consistently use the health coaches, app tools, and community features, you are paying for a service layer that adds cost without adding clinical value to your specific situation.
The Coaching Premium: Is Found's Bundle Worth It Without Insurance?
Found's Coaching Bundle — Two Honest Perspectives
The Best Cash-Pay GLP-1 Alternatives to Found in 2026
Free Alternatives to Found's Coaching Bundle
If you choose a medication-only platform like Luma Health instead of Found, the coaching features you'd be leaving behind are almost all available for free elsewhere. The incremental weight loss from behavioral support is real — these tools provide that support without a monthly platform subscription.
📋 Food Tracking (replaces Found app)
MyFitnessPal (free), Cronometer (free), and Lose It! (free tier) all provide comprehensive calorie and macro tracking. These are more detailed than Found's integrated tracking and cost nothing.
🤝 Community Support (replaces Found community)
Reddit communities (r/semaglutide, r/Tirzepatide, r/loseit) are active, candid, and free. Often more useful than platform-managed communities because they include unfiltered patient experiences.
🏅 Registered Dietitian (replaces Found coaching)
One session/month with an RD who works with GLP-1 patients: ~$80–$150/session. You pay only when you use it. More clinically qualified than general health coaches and at lower monthly cost than Found's bundled premium for most patients.
🎧 Education Resources (free)
Podcasts, YouTube content from registered dietitians, and free CBT workbooks provide the educational content Found's coaching delivers at no cost.
Same molecule. Flat rate.
No coaching fee you might not use.
Compounded semaglutide $197/month flat, tirzepatide $297/month flat. VialsRX pharmacy (TX Board #35264). No contracts.
Start With Luma Health →Frequently Asked Questions
For patients who won't use Found's behavioral coaching consistently, Luma Health at $197/month flat for semaglutide is a direct alternative with comparable pricing at maintenance doses — and better pharmacy transparency (VialsRX, TX #35264, publicly named). For patients who will genuinely use behavioral coaching, Found's bundle may be the right choice despite the dose-tier pricing complexity. There is no universally "better" option — the answer depends on how much you value the coaching component.
Found's cash-pay semaglutide ranges from approximately $129/month at starting doses (0.25 mg/week) to $179–$199/month at maintenance doses (1.7–2.4 mg/week). The starting price is attractive but not the price you'll pay for most of your treatment time. The full-year cost at maintenance is approximately $2,148 to $2,388. Found's pricing also includes behavioral coaching that cannot be removed from the subscription. Verify current Found pricing directly at joinfound.com.
Yes. Both Found and Luma Health prescribe compounded semaglutide — the same active pharmaceutical molecule at equivalent pharmacological doses, prepared by licensed 503A sterile compounding pharmacies. The STEP 1 clinical trial data (14.9% average weight loss at 68 weeks at 2.4 mg/week) applies to the semaglutide molecule regardless of which licensed platform prescribes it. The differences are in bundled services, pricing structure, pharmacy transparency, and commitment requirements — not in the medication itself.
Yes. Found offers compounded tirzepatide at approximately $199 to $249/month without insurance. This is generally less expensive than Luma Health's $297/month flat, and comparable to or cheaper than other compounded tirzepatide providers' maintenance-dose pricing once dose-tier increases are factored in. Found sits with coaching bundled in; Luma Health offers a flat rate with no coaching.
If behavioral coaching is clinically important to you and you want the lowest combined cost, consider a hybrid approach: enroll with a medication-only provider like Luma Health ($197/month sema) and add free or low-cost coaching separately. Free options: MyFitnessPal for tracking, Reddit communities for peer support. Paid option: one monthly session with a registered dietitian ($80–$150, pay as you use it). Total cost: $197 to $347/month depending on RD frequency — potentially less than Found's bundled total at maintenance doses, while giving you more specialized coaching than a general health coach platform provides.
Neither Luma Health nor Found require insurance. Both platforms operate on a cash-pay model for compounded semaglutide and tirzepatide. No prior authorization, no formulary requirements, no coverage denials — you pay the monthly rate and receive medication. Luma Health's semaglutide is $197/month flat; Found's is $129–$199/month (dose-tier). For patients who eventually want to explore brand-name coverage through insurance, platforms with dedicated insurance navigation (such as Ro or LifeMD) may be worth exploring separately.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy. JAMA. 2021;325(14):1403–1413. PubMed 33755729
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- Found Health. Official Website and Pricing. joinfound.com
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- FDA. BeSafeRx — Online Pharmacy Verification. FDA.gov